Seaport Therapeutics is building a fail-safe into its Phase 2b depression trial.
The biotech is testing its drug, called SPT-300, in patients with major depressive disorder. But executives believe SPT-300 could prove more promising in …
Merck’s drug enlicitide beat a handful of commonly used cholesterol-lowering drugs in a comparator trial, inching it closer to becoming the first oral PCSK9 inhibitor.
During this year’s American Academy of Dermatology annual meeting in Denver, companies like Sanofi, Biogen and Tanabe Pharma presented data for their respective candidates. But
Attempts by the White House to curry industry support for legislation that would codify last year’s voluntary drug pricing deals are being ignored by some
Nearly all of Incheon-headquartered Samsung Biologics’ union members have supported plans to strike over wage negotiations, after an internal employee data leak in November. The
Two decades ago, when I was a baby-faced Capitol Hill reporter, Texas Republican Michael Burgess was a relatively new member of Congress, swept in with
Seaport Therapeutics is building a fail-safe into its Phase 2b depression trial.
The biotech is testing its drug, called SPT-300, in patients with major depressive disorder. But executives believe SPT-300 could prove more promising in …